<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04181853</url>
  </required_header>
  <id_info>
    <org_study_id>60116787-020/83243</org_study_id>
    <nct_id>NCT04181853</nct_id>
  </id_info>
  <brief_title>The Effect of Aerobic Exercise on Genetic Molecules</brief_title>
  <acronym>xnx</acronym>
  <official_title>The Effect of Aerobic Exercise on Genetic Molecules Related With Metabolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pamukkale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pamukkale University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the effects of high intensity interval exercise and
      moderate intensity continuous exercise on some genetic molecules in patients with type 2
      diabetes mellitus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Volunteers with type 2 diabetes mellitus will be evaluated in terms of any contra-indication
      that will restrain them from making exercise. 90 male or female volunteers who are suitable
      in terms of inclusion/exclusion criteria will be invited for the study. Volunteers will be
      randomly distributed to one of the 3 groups. Each group will contain 30 participants. 1.
      group will make aerobic exercise which is in the form of high intensity interval exercise
      2.group will make aerobic exercise which is in the form of moderate intensity continuous
      exercise 3. Control group. Exercise groups will be cycling under observation in the hospital
      setting. Control group will make simple stretching exercises at home. Participants will be
      requested to complete a 3 months of exercise. They will be evaluated before and at the end of
      the 3 months of exercise with blood tests to measure genetic molecules related with
      metabolism.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 5, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The study has 3 arms</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>Participants wil be making exercise. It is not possible to make participants blinded to the study.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>genetic molecules</measure>
    <time_frame>12 weeks</time_frame>
    <description>HbA1c level in the serum</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <condition>Aerobic Exercise</condition>
  <condition>Genetic Response</condition>
  <arm_group>
    <arm_group_label>High intensity interval exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants with type 2 Diabetes mellitus in High intensity interval exercise (HIIE) group will make aerobic exercise using bicycle at high intensity followed by low intensity periods under observation in the hospital.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate intensity continuous exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants with type 2 Diabetes mellitus in Moderate intensity continuous exercise (MIC) group will make aerobic exercise using bicycle at moderate intensity during the session under observation in the hospital.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Intervention: Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants with type 2 Diabetes mellitus in Moderate intensity continuous exercise (MIC) group will make aerobic exercise using bicycle at moderate intensity during the session under observation in the hospital.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>exercise</intervention_name>
    <description>aerobic exercise</description>
    <arm_group_label>High intensity interval exercise</arm_group_label>
    <arm_group_label>Moderate intensity continuous exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Clinica diagnosis of type 2 Diabetes mellitus less than 10 years and more than 1 year.

          -  must have appropriate medical therapy and diet.

          -  must not be treated with insulin.

          -  must be exercising less than 210 minutes/ week

        Exclusion Criteria:

          -  prominent cardiovascular disease

          -  coronary artery disease

          -  moderate to severe valvular disease

          -  atrial fibrillation

          -  untreated hypertension

          -  congenital heart disease

          -  retinopathy

          -  neuropathy

          -  macro albuminuria

          -  cerebrovascular disease

          -  ejection fraction less than 40

          -  body mass index greater than 35.

          -  prominent ischemic changes in EKG at rest or during exercise.

          -  cigarette or alcohol addiction

          -  on drugs that interferes with body fat distribution (such as insulin,
             thiazolidinediones
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gulin Findikoglu, Assoc Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pamukkale University,Medical Faculty, PMR Department</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>GÜLİN FINDIKOGLU, Assoc Prof</last_name>
    <phone>05334227076</phone>
    <email>gulin_dr@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pamukkale University</name>
      <address>
        <city>Denizli</city>
        <zip>20100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>GÜLİN FINDIKOGLU, Assoc prof MD PhD</last_name>
      <phone>05334227076</phone>
      <email>gulin_f@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pamukkale University</name>
      <address>
        <city>Denizli</city>
        <zip>21600</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gulin Findikoglu, MD, PhD</last_name>
      <phone>90 258 2966000</phone>
      <phone_ext>4956</phone_ext>
      <email>gulin_dr@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Abdurrahim Altınkapak, MD</last_name>
      <phone>90 258 2966000</phone>
      <phone_ext>6781</phone_ext>
      <email>abdurrahim_alt@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>November 23, 2019</study_first_submitted>
  <study_first_submitted_qc>November 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 2, 2019</study_first_posted>
  <last_update_submitted>February 5, 2020</last_update_submitted>
  <last_update_submitted_qc>February 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pamukkale University</investigator_affiliation>
    <investigator_full_name>GULIN FINDIKOGLU</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Type 2 diabetes mellitus</keyword>
  <keyword>exercise</keyword>
  <keyword>aerobic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

